COVID-19 vaccine maker Johnson & Johnson splitting into two companies
Global News
Johnson & Johnson, a medical manufacturing titan and COVID-19 vaccine maker, has announced it is dividing its business into two companies for better market impact.
Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business.
The company said Friday the move will help improve the focus and speed of each company to address trends in their different industries.
The company selling prescription drugs and medical devices will keep Johnson & Johnson as its name, the company said Friday. That company will include treatments such as Darzalex, Erleada, Imbruvica, Stelara and Tremfya as well as medical device solutions across interventional solutions, orthopaedics, surgery and vision.
The prescription drug arm also makes one of three COVID-19 vaccines currently approved for use in the United States.
The new consumer health company will house brands including Neutrogena, Aveeno, Tylenol, Listerine, Johnson’s, and Band-Aid. It is expected to generate revenue of approximately US$15 billion for the year. A name was not disclosed for the new company.
“Following a comprehensive review, the board and management team believe that the planned separation of the consumer health business is the best way to accelerate our efforts to serve patients, consumers, and healthcare professionals, create opportunities for our talented global team, drive profitable growth, and – most importantly – improve healthcare outcomes for people around the world,” CEO Alex Gorsky said in a statement.
Details are sparse, but Johnson & Johnson expects the split to occur in the next two years, if approved by the company board.
The announcement comes just days after General Electric said that it plans to split into three separate companies.
A chemical engineer out of the University of Calgary is piloting what she says is a more efficient, cleaner lithium extraction process.
The World Health Organization has authorized the first mpox vaccine for children, a decision experts hope will help make immunizations more widely available.
California's public health department reported a possible case of bird flu in a child with mild respiratory symptoms, but said there was no evidence of human-to-human transmission.
The AER says the company must report any hazards that present a risk to public safety or the environment.
Trump nominated Oz as administrator for the Centers for Medicare and Medicaid Services and Howard Lutnick as his next U.S. commerce secretary, who would oversee tariff policy.
Bird flu has spread far and wide, infecting a range of species like chickens, skunks, cows, foxes and polar bears. But it's the pigs that have experts on high alert.
The CFIA has recalled E. coli-tainted carrots, following a U.S. health warning about the contaminated produce linked to one death and dozens of illnesses.
Health Canada said there was an issue with the braking system of the Stokke YOYO baby stroller, sold between August and October this year.
These editorial stories and interviews will focus on the people, companies, research, and innovations leading the environmental and sustainable movement in B.C.
Bennett had just returned from the school run last week when she found the mom and a baby raccoon unconscious, with one of the babies sleeping on the furniture.
B.C. health authorities have announced the first case of a human avian flu infection acquired in Canada, with the teenage patient in critical condition in hospital.